BioPharmSignal logoBioPharmSignal

Biotech News

LifeStance Reports Fourth Quarter and Full Year 2025 Results

LifeStance Health (LFST)LifeStance HealthEarnings

Announces $100 Million Share Repurchase Program SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended

Related news

LFSTLifeStance Health2026-02-09 21:10 EST

LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

LFSTLifeStance Health2026-08-06 10:00 EST

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

View all latest news

LifeStance Health

Outpatient Mental Healthcare LifeStance Health is one of the largest U.S. providers of outpatient mental-health services for children, adolescents and adults. Its clinicians treat a broad range of behavioral-health conditions through therapy and psychiatric care. Hybrid Care Network The company combines in-person practices with virtual...

Recent company news

LFSTLifeStance Health2026-08-06 10:00 EST

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

LFSTLifeStance Health2026-07-16 20:10 EST

LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026

LFSTLifeStance Health2026-05-08 02:18 EST

LifeStance Health Group Announces Pricing of Secondary Public Offering

LFSTLifeStance Health2026-05-07 20:51 EST

LifeStance Health Group Announces Launch of Secondary Public Offering

LFSTLifeStance Health2026-05-07 10:00 EST

LifeStance Reports First Quarter 2026 Results

Stock data

Close
10.66 USD
Market cap
2.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States